Damora Therapeutics (DMRA) Operating Leases (2019 - 2025)
Damora Therapeutics posted quarterly Operating Leases of $53000.0 for Q4 2025, down 13.11% year-on-year from $61000.0 in Q4 2024, and down 7.02% on a QoQ basis from $57000.0 in Q3 2025.
Damora Therapeutics (DMRA) has 7 years of Operating Leases data on file, last reported at $53000.0 in Q4 2025.
- For the quarter ending Q4 2025, Operating Leases fell 13.11% year-over-year to $53000.0; the trailing twelve-month figure through Dec 2025 stood at $53000.0 (down 13.11% YoY), and the FY2025 full-year result was $53000.0, down 13.11% from the prior year.
- Operating Leases for Q4 2025 stood at $53000.0, down from $57000.0 in the prior quarter.
- Across five years, Operating Leases topped out at $635000.0 in Q2 2021 and bottomed at $53000.0 in Q4 2025.
- The 5-year median for Operating Leases is $234000.0 (2023), against an average of $266000.0.
- The widest annual swing landed in 2023, when Operating Leases tumbled 79.88%; it then dropped 7.58% in 2024.
- A 5-year view of Operating Leases shows it stood at $448000.0 in 2021, then fell by 26.79% to $328000.0 in 2022, then sank by 79.88% to $66000.0 in 2023, then declined by 7.58% to $61000.0 in 2024, then decreased by 13.11% to $53000.0 in 2025.
- The last three Operating Leases figures came in at $53000.0 (Q4 2025), $57000.0 (Q3 2025), and $60000.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Damora Therapeutics | 853.36 Mn | 650.97 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 53,000.00 |
| Sep 30, 2025 | 57,000.00 |
| Jun 30, 2025 | 60,000.00 |
| Mar 31, 2025 | 60,000.00 |
| Dec 31, 2024 | 61,000.00 |
| Dec 31, 2023 | 66,000.00 |
| Sep 30, 2023 | 112,000.00 |
| Jun 30, 2023 | 206,000.00 |
| Mar 31, 2023 | 234,000.00 |
| Dec 31, 2022 | 328,000.00 |
| Sep 30, 2022 | 440,000.00 |
| Jun 30, 2022 | 305,000.00 |
| Mar 31, 2022 | 402,000.00 |
| Dec 31, 2021 | 448,000.00 |
| Sep 30, 2021 | 511,000.00 |
| Jun 30, 2021 | 635,000.00 |
| Mar 31, 2021 | 544,000.00 |
| Dec 31, 2020 | 541,000.00 |
| Sep 30, 2020 | 589,000.00 |
| Dec 31, 2019 | 211,000.00 |